Concomitant Statin Use Has a Favorable Effect on Gemcitabine-Erlotinib Combination Chemotherapy for Advanced Pancreatic Cancer

PURPOSE: Erlotinib-gemcitabine combined chemotherapy is considered as the standard treatment for unresectable pancreatic cancer. This study aimed to determine the clinical factors associated with response to this treatment. MATERIALS AND METHODS: This retrospective study included 180 patients with u...

Descripción completa

Detalles Bibliográficos
Autores principales: Moon, Do Chang, Lee, Hee Seung, Lee, Yong Il, Chung, Moon Jae, Park, Jeong Youp, Park, Seung Woo, Song, Si Young, Chung, Jae Bock, Bang, Seungmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4960377/
https://www.ncbi.nlm.nih.gov/pubmed/27401642
http://dx.doi.org/10.3349/ymj.2016.57.5.1124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4960377/
https://www.ncbi.nlm.nih.gov/pubmed/27401642
http://dx.doi.org/10.3349/ymj.2016.57.5.1124

Ejemplares similares